With these improvements in hand, company founder Richard Carlton plans phase 1 tests early next year for vancomycin-resistant Enterococcus faecium infections. Although antibodies would rapidly ...

Background Vancomycin-resistant enterococci are a leading cause of hospital-acquired urinary tract infection and a growing concern for the clinician. The aim of this study was to evaluate the ...

In light of the scarcity of treatment options for VRE UTI and clinical data related to daptomycin use in this setting, the purpose of this report is to describe the clinical experience with ...

Good infection prevention in hospitals helps stop its spread. Vancomycin-intermediate (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) are forms of the bug that have become resistant to ...

My work is focused on the study of the bacterial cell wall using essentially two Gram-positive pathogens (Staphylococcus aureus, Enterococcus faecalis) as models. I am interested in three major areas ...

To make MRSA matters even worse, in 2002, health care workers reported the first cases of vancomycin-resistant MRSA. In other words, even "last-resort" vancomycin doesn't always work. Therein lies ...